HCAR2 and colorectal cancer: According to these results, the suppressing impact of butyrate on glucose uptake in colorectal cancer cells is mostly likely activated by GPR109a, which elicits a decreased level of phosphorylated AKT and subsequently reduced membrane content of GLUT1.